Abstract
Efficiently scouting the chemical space is one of the major challenges for lead discovery for drug development. In recent times some shifts have been made away from HTS and combinatorial chemistry to more focused approaches. Combinatorial chemistry was the starting point for the development of synthesis concepts that were intended to cover and explore the chemical space without having to prepare every individual compound. In this review, these lead finding approaches will be discussed comparing virtual and synthesized libraries. In addition we discuss the concepts and relationships of evolutionary libraries using genetic algorithms and dynamic combinatorial chemistries, as well as templated fragment ligation concepts. Taking a more abstract view of all approaches, the concepts may loop back into Combinatorial Chemistry allowing a more educated choice of building blocks and chemistries.
Keywords: pharmacological screening, genomic, high-throughput identification, drug discovery, mass spectrometry, oligonucleotides, combinatorial synthesis, mrna, dynamic combinatorial library, thermodynamics
Current Drug Discovery Technologies
Title: Combinatorial Chemistry and Fragment Screening - Two Unlike Siblings?
Volume: 2 Issue: 1
Author(s): Hans Peter Nestler
Affiliation:
Keywords: pharmacological screening, genomic, high-throughput identification, drug discovery, mass spectrometry, oligonucleotides, combinatorial synthesis, mrna, dynamic combinatorial library, thermodynamics
Abstract: Efficiently scouting the chemical space is one of the major challenges for lead discovery for drug development. In recent times some shifts have been made away from HTS and combinatorial chemistry to more focused approaches. Combinatorial chemistry was the starting point for the development of synthesis concepts that were intended to cover and explore the chemical space without having to prepare every individual compound. In this review, these lead finding approaches will be discussed comparing virtual and synthesized libraries. In addition we discuss the concepts and relationships of evolutionary libraries using genetic algorithms and dynamic combinatorial chemistries, as well as templated fragment ligation concepts. Taking a more abstract view of all approaches, the concepts may loop back into Combinatorial Chemistry allowing a more educated choice of building blocks and chemistries.
Export Options
About this article
Cite this article as:
Nestler Peter Hans, Combinatorial Chemistry and Fragment Screening - Two Unlike Siblings?, Current Drug Discovery Technologies 2005; 2 (1) . https://dx.doi.org/10.2174/1570163053175484
DOI https://dx.doi.org/10.2174/1570163053175484 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Resistance to Aspirin and Thienopyridines in Diabetes Mellitus and Metabolic Syndrome
Current Vascular Pharmacology Connexins in Renal Endothelial Function and Dysfunction
Cardiovascular & Hematological Disorders-Drug Targets The Leading Role of Antimicrobial Agents in Modulating the Binomial Host-Microorganism
Current Medicinal Chemistry - Anti-Infective Agents Network Pharmacology Analysis on Zhichan Powder in the Treatment of Parkinson's Disease
Combinatorial Chemistry & High Throughput Screening The Human Indoleamine 2,3-Dioxygenase Gene and Related Human Genes
Current Drug Metabolism MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion
Current Medicinal Chemistry A Role of Immunotherapy in Metastatic Malignant Melanoma
Central Nervous System Agents in Medicinal Chemistry Nanoparticle Albumin - Bound (NAB) Technology is a Promising Method for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
CNS & Neurological Disorders - Drug Targets The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
Current Molecular Medicine Differential Effects of Efavirenz and Lopinavir/Ritonavir on Human Adipocyte Differentiation, Gene Expression and Release of Adipokines and Pro-Inflammatory Cytokines.
Current HIV Research The Potential Role of Gut Microbiota in the Pathogenesis of Type 2 Diabetes Mellitus <i>via</i> Epigenetics and Inflammasome
Endocrine, Metabolic & Immune Disorders - Drug Targets Zein-Based Nanofibres for Drug Delivery: Classes and Current Applications
Current Pharmaceutical Design Busulfan Use in Hematopoietic Stem Cell Transplantation: Pharmacology, Dose Adjustment, Safety and Efficacy in Adults and Children
Current Drug Safety Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle
Current Medicinal Chemistry Anti-Inflammatory Role of Fetuin-A in Injury and Infection
Current Molecular Medicine Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Current Cancer Drug Targets Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile
Current Drug Safety Endogenous Cardiotonics: Search and Problems
Cardiovascular & Hematological Disorders-Drug Targets Potential Targets and Their Relevant Inhibitors in Anti-influenza Fields
Current Medicinal Chemistry